Hood River Capital Management LLC Harmony Biosciences Holdings, Inc. Transaction History

Hood River Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $178,169 - $218,060	5,587 Added 1.79%	318,544 $10.4 Million
Q2 2023 Aug 14, 2023	SELL	$30.5 - $37.4 $23,332 - $28,611	-765 Reduced 0.24%	312,957 $11 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $611,534 - $1.07 Million	19,855 Added 6.76%	313,722 $10.2 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $82,128 - $110,186	1,809 Added 0.62%	293,867 $16.2 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $271,034 - $357,319	6,444 Added 2.26%	292,058 $12.9 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $447,054 - $695,107	-13,329 Reduced 4.46%	285,614 $13.9 Million
Q1 2022 May 16, 2022	BUY	$33.14 - $51.13 $9.91 Million - $15.3 Million	298,943 New	298,943 $14.5 Million

246

45.5M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.29B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hood River Capital Management LLC with notifications on news.